Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Acq. announced CC transcript
|
SCIELE PHARMA, INC. (SCRX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/10/2009 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
02/03/2009 |
SC 13G/A
| BARCLAYS GLOBAL INVESTORS NA reports a 0% stake in SCIELE PHARMA INC |
10/09/2008 |
8-K
| Quarterly results |
09/03/2008 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs:
|
"Agreement and Plan of Merger, among Shionogi & Co., Ltd., Tall Bridge, Inc. and Sciele Pharma, Inc.",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Patrick Fourteau",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Edward Schutter",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Darrell Borne",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Leslie Zacks",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Larry Dillaha",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Joseph Ciaffoni",
"SHIONOGI & CO., LTD. TO ACQUIRE SCIELE PHARMA, INC. SIGNIFICANTLY INCREASES SHIONOGI'S PRESENCE IN THE UNITED STATES",
"Form of Tender and Voting Agreement" |
|
08/27/2008 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
08/18/2008 |
4
| FOURTEAU PATRICK (CEO) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Exercised 100,000 shares
@ $0 Sold 100,000 shares
@ $21.3739, valued at
$2.1M
Exercised 50,000 options
@ $11.455, valued at
$572.8k
|
|
08/12/2008 |
4
| Dillaha Larry (EVP and Chief Medical Officer) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Sold 875 shares
@ $20.336, valued at
$17.8k
|
|
07/31/2008 |
10-Q
| Quarterly Report for the period ended June 30, 2008 |
07/30/2008 |
8-K
| Quarterly results |
07/30/2008 |
TRN
| Sciele Pharma Inc. Q2 2008 Earnings Call Transcript |
07/01/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
05/28/2008 |
4
| SAXE JON S (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Exercised 3,750 shares
@ $0 Sold 3,750 shares
@ $21.08, valued at
$79.1k
Exercised 3,750 options to buy
@ $18.917, valued at
$70.9k
|
|
05/28/2008 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Exercised 3,750 shares
@ $0 Sold 3,750 shares
@ $21.08, valued at
$79.1k
Exercised 3,750 options to buy
@ $18.917, valued at
$70.9k
|
|
05/28/2008 |
4
| ELLIS JERRY N (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Exercised 3,750 shares
@ $0 Sold 3,750 shares
@ $21.08, valued at
$79.1k
Exercised 3,750 options
@ $18.917, valued at
$70.9k
|
|
05/23/2008 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
05/19/2008 |
4
| Zacks Leslie (EVP/Chief Legal Compl. Officer) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Sold 1,625 shares
@ $21.71, valued at
$35.3k
|
|
05/19/2008 |
4
| FOURTEAU PATRICK (CEO) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Exercised 100,000 shares
@ $0 Sold 100,000 shares
@ $21.0761, valued at
$2.1M
Exercised 50,000 options
@ $11.455, valued at
$572.8k
|
|
05/01/2008 |
10-Q
| Quarterly Report for the period ended March 31, 2008 |
04/30/2008 |
8-K
| Quarterly results |
04/30/2008 |
TRN
| Sciele Pharma, Inc. Q1 2008 Earnings Call Transcript |
04/28/2008 |
4
| Dillaha Larry (EVP and Chief Medical Officer) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Sold 350 shares
@ $19.35, valued at
$6.8k
|
|
04/28/2008 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
04/28/2008 |
4
| ZENNER PATRICK J (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
04/28/2008 |
4
| Robinson William John (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
04/28/2008 |
4
| ELLIS JERRY N (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
04/28/2008 |
4
| Griffin Jerry C (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
04/28/2008 |
4
| SAXE JON S (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
04/28/2008 |
8-K
| Material Modifications to Rights of Security Holders, Other Events, Financial Statements and Exhibits |
04/03/2008 |
4
| SCHUTTER EDWARD J (President & COO) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Sold 2,500 shares
@ $20.72, valued at
$51.8k
|
|
03/18/2008 |
4
| LAPALME PIERRE (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Bought 100 shares
@ $18.4101, valued at
$1.8k
Bought 100 shares
@ $18.44, valued at
$1.8k
Bought 1,800 shares
@ $18.41, valued at
$33.1k
|
|
03/17/2008 |
4
| ZENNER PATRICK J (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns:
| Bought 1,100 shares
@ $18.45, valued at
$20.3k
Bought 500 shares
@ $18.46, valued at
$9.2k
Bought 400 shares
@ $18.47, valued at
$7.4k
Bought 500 shares
@ $18.48, valued at
$9.2k
Bought 1 shares
@ $18.49, valued at
$18.5 Bought 204 shares
@ $18.5, valued at
$3.8k
|
|
03/14/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
03/12/2008 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
|
|
|